joel habener glp 1 Friends of the National Library of Medicine to Honor Dr. Habener, Dr. Svetlana Mojsov, and Dr. Lotte Bjerre Knudsen at Awards Gala Scientists Who Pioneered GLP-1 Drugs

doi: 10.3389/fendo.2013.00174 50 KrassasGEPerrosP

When designing comprehensive peptide protocols, practitioners might also consider complementary compounds available from specialized peptide suppliers to address multiple therapeutic targets simultaneously

In autoimmune hepatitis and T-cell-mediated hepatitis models, gut microbiota-derived ICA induces the expression of PI3K-interacting protein 1 by activating AhR in CD8 + T cells, thereby inhibiting the PI3K/Akt/mTOR pathway, limiting excessive activation of effector T cells, and attenuating liver injury

Five half-lives (roughly 5 weeks) covers near-complete elimination, and the 2-month buffer adds a safety margin for patients who are actively attempting conception

2025 Jan 8;17(1):14